Exploring mitochondrial genetic features in intervertebral disc degeneration through multi-omics integration analyses
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 07.05.2026 · 81 (6)
DOI: 10.1093/gerona/glag121 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 12.05.2026. Verfasst von Fangxing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, DNA, Mitochondrial, Mitochondria. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province of China.
Abstract (Originalsprache)
The mitochondrial genetic basis of intervertebral disc degeneration (IVDD) remains incompletely understood. This study employed multi-omics Mendelian randomization (MR) analysis to investigate the potential mitochondrial-related genetic mechanisms underlying IVDD. Using two-sample MR, we integrated and analyzed multi-omics quantitative trait loci, encompassing methylation, expression, protein abundance, and mitochondrial DNA, from genome-wide association studies (GWAS). Genetic associations with IVDD were obtained from the FinnGen study for discovery and the GWAS Catalog database for validation, with Steiger filtering and co-localization analysis further performed to strengthen causal inference. Additionally, Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and drug prediction analyses were comprehensively employed to identify potential therapeutic targets. Our multi-omics evidence identified 23 genes, among which 5 genes (glycine amidinotransferase [GATM], SLC25A13, acyl-CoA dehydrogenase short [ACADS], TSFM, and ATP23) showed tier 1 evidence for IVDD, with GATM demonstrating the strongest support. MR analysis revealed that a higher level of GATM was associated with a reduced risk of IVDD (odds ratio: 0.934, 95% confidence interval, 0.887-0.983). Furthermore, 15 drugs targeting GATM were identified, with HYDRONIDONE completing molecular docking. Through the integration of multi-omics data, we identified 5 promising therapeutic targets for IVDD, with GATM exhibiting the most consistent multi-omics signal, and discovered 15 drugs targeting GATM and 11 drugs targeting ACADS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Cardiology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Pharmacy, Harbin Second Hospital, Harbin, China.
- Department of Oncology, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
ORCID-Profile: Meng Sun, Pengyu Kong
Förderung
- Natural Science Foundation of Heilongjiang Province of China
Zitieren
APA
Xu, F., Wang, C., Sun, M., Shi, S., Wang, X., Liu, D., Yu, L., Xi, C., & Kong, P. (2026). Exploring mitochondrial genetic features in intervertebral disc degeneration through multi-omics integration analyses. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(6). https://doi.org/10.1093/gerona/glag121
Vancouver
Xu F, Wang C, Sun M, Shi S, Wang X, Liu D, et al. Exploring mitochondrial genetic features in intervertebral disc degeneration through multi-omics integration analyses. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(6). doi:10.1093/gerona/glag121
BibTeX
@article{Xu2026,
author = {Xu, Fangxing and Wang, Chao and Sun, Meng and Shi, Shuai and Wang, Xuyao and Liu, Donghui and Yu, Lianhao and Xi, Chunyang and Kong, Pengyu},
title = {Exploring mitochondrial genetic features in intervertebral disc degeneration through multi-omics integration analyses},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/gerona/glag121}
}
EUVIMED